M Judith Peterschmitt Selected Research

Pharmaceutical Preparations

1/2020	Effect of eliglustat on the pharmacokinetics of digoxin, metoprolol, and oral contraceptives and absorption of eliglustat when coadministered with acid-reducing agents.
1/2018	A pooled analysis of adverse events in 393 adults with Gaucher disease type 1 from four clinical trials of oral eliglustat: Evaluation of frequency, timing, and duration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M Judith Peterschmitt Research Topics

Disease

23	Gaucher Disease (Gaucher's Disease) 01/2021 - 08/2010
3	Splenomegaly 10/2021 - 02/2015
3	Anemia 01/2019 - 11/2010
2	Parkinson Disease (Parkinson's Disease) 01/2022 - 01/2021
2	Thrombocytopenia (Thrombopenia) 01/2019 - 12/2016
1	Confusion (Bewilderment) 01/2022
1	Panic Disorder (Panic Attack) 01/2022
1	Metabolic Bone Diseases (Osteopenia) 01/2021
1	Fabry Disease (Fabry's Disease) 01/2021
1	GM2 Gangliosidoses (GM2 Gangliosidosis) 01/2021
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2021
1	Hepatomegaly 09/2020
1	Niemann-Pick Diseases (Niemann Pick Disease) 09/2020
1	Fibrosis (Cirrhosis) 09/2020
1	Urinary Tract Infections (Urinary Tract Infection) 01/2020
1	Spontaneous Abortion (Miscarriage) 01/2020
1	Fatigue 01/2018
1	Diarrhea 01/2018
1	Abdominal Pain (Pain, Abdominal) 01/2018
1	Arthralgia (Joint Pain) 01/2018
1	Flatulence 01/2018
1	Headache (Headaches) 01/2018
1	Pain (Aches) 01/2018
1	Back Pain (Backache) 01/2018
1	Nausea 01/2018
1	Maple Syrup Urine Disease 04/2002

Drug/Important Bio-Agent (IBA)

22	eliglustatIBA 01/2021 - 08/2010
8	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2020 - 09/2016
6	Hemoglobins (Hemoglobin)IBA 01/2021 - 11/2010
4	Glucosylceramides (Glucocerebrosides)IBA 01/2022 - 12/2016
3	LipidsIBA 01/2021 - 11/2017
3	AcidsIBA 01/2021 - 12/2016
3	ceramide glucosyltransferaseIBA 03/2020 - 08/2010
3	imiglucerase FDA Link 01/2017 - 09/2016
2	venglustatIBA 01/2022 - 01/2021
2	GlucosidasesIBA 01/2021 - 12/2016
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 11/2017
2	sphingosyl beta-glucosideIBA 01/2021 - 11/2017
2	EnzymesIBA 09/2020 - 12/2016
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2018
1	Glucosylceramidase (Glucocerebrosidase)IBA 01/2022
1	GlycosphingolipidsIBA 01/2022
1	chitotriosidaseIBA 01/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2020
1	olipudase alfaIBA 09/2020
1	SphingomyelinsIBA 09/2020
1	Ketoconazole (Nizoral)FDA LinkGeneric 03/2020
1	Rifampin (Rifampicin)FDA LinkGeneric 03/2020
1	Paroxetine (Paxil)FDA LinkGeneric 03/2020
1	Digoxin (Digitek)FDA LinkGeneric 01/2020
1	Cytochrome P-450 CYP3AIBA 01/2020
1	Combined Oral ContraceptivesIBA 01/2020
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2020
1	Reducing AgentsIBA 01/2020
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2020
1	Branched-Chain Amino AcidsIBA 04/2002
1	Oxidoreductases (Dehydrogenase)IBA 04/2002

Therapy/Procedure

18	Therapeutics 01/2021 - 08/2010
4	Enzyme Replacement Therapy 01/2019 - 11/2010
1	Splenectomy 10/2021
1	Enzyme Therapy 01/2017
1	Renal Dialysis (Hemodialysis) 04/2002